Cai Lay Veterinary Pharmaceutical JSC

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000MKV4
VND
15,300.00
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
33,826.42
33,412.39
27,687.82
30,767.20
27,383.74
24,143.05
29,254.27
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
33,826.42
33,412.39
27,687.82
30,767.20
27,383.74
24,143.05
29,254.27
Raw Material Cost
22,521.81
23,781.38
18,018.41
18,820.05
17,520.58
16,749.90
20,483.72
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
4,878.58
5,770.73
5,865.66
3,927.03
2,827.50
2,807.98
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
5.41
33.11
0.00
735.16
Selling and Distribution Expenses
7,533.52
6,588.17
8,340.80
8,941.06
4,871.84
4,575.33
5,857.11
Other Expenses
-487.86
-577.07
-586.57
-393.24
-286.06
-280.80
-73.52
Total Expenditure (Excl Depreciation)
30,055.33
30,369.55
26,359.22
27,761.11
22,392.42
21,325.23
26,340.83
Operating Profit (PBDIT) excl Other Income
3771.1000000000004
3042.7999999999997
1328.6000000000001
3006.1000000000004
4991.3
2817.7999999999997
2913.3999999999996
Other Income
-934.61
-582.82
-972.49
-689.38
-578.11
-584.54
67.28
Operating Profit (PBDIT)
3,880.30
3,490.99
1,397.84
3,358.43
5,469.57
3,315.26
4,755.46
Interest
0.00
0.00
0.00
5.41
33.11
0.00
735.16
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
11,304.60
9,631.01
9,669.40
11,947.15
9,863.16
7,393.15
8,770.54
Depreciation
1,043.82
1,043.41
1,041.72
1,041.72
1,056.35
1,094.43
1,774.74
Profit Before Tax
2,836.47
2,447.58
356.11
2,311.29
4,380.10
2,220.83
2,245.56
Tax
567.31
489.70
102.38
463.97
876.10
444.17
449.11
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
2,269.16
1,957.88
253.74
1,847.32
3,504.00
1,776.66
1,796.45
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
2,269.16
1,957.88
253.74
1,847.32
3,504.00
1,776.66
1,796.45
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
2,269.16
1,957.88
253.74
1,847.32
3,504.00
1,776.66
1,796.45
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
10000.0
10000.0
10000.0
10000.0
10000.0
10000.0
10000.0
Reserves
91,372.96
89,103.80
87,145.93
86,949.61
85,102.29
81,598.29
79,821.62
Earnings per share (EPS)
453.83
391.58
50.75
369.46
700.8
355.33
359.29
Diluted Earnings per share
453.83
391.58
50.75
369.46
700.8
355.33
359.29
Operating Profit Margin (Excl OI)
11.15%
9.07%
4.8%
9.77%
18.23%
11.62%
9.96%
Gross Profit Margin
11.47%
10.45%
5.05%
10.9%
19.85%
13.73%
13.74%
PAT Margin
6.71%
5.86%
0.92%
6.0%
12.8%
7.36%
6.14%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is 1.24% vs 20.68% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is 15.90% vs 671.74% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is 18.19% vs 71.87% in Mar 2025

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

Compare Quarterly Results Of Cai Lay Veterinary Pharmaceutical JSC With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(VND)
Change(%)
Net Sales
33,826.42
82,515.37
-48,688.95
-59.01%
Other Operating Income
0.00
0.00
0.00
Total Operating income
33,826.42
82,515.37
-48,688.95
-59.01%
Raw Material Cost
22,521.81
67,727.57
-45,205.76
-66.75%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
4,878.58
0.00
4,878.58
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
1,574.99
-1,574.99
-100.00%
Selling and Distribution Expenses
7,533.52
9,067.45
-1,533.93
-16.92%
Other Expenses
-487.86
-157.50
-330.36
-209.75%
Total Expenditure (Excl Depreciation)
30,055.33
76,795.02
-46,739.69
-60.86%
Operating Profit (PBDIT) excl Other Income
3,771.09
5,720.35
-1,949.26
-34.08%
Other Income
-934.61
-24.92
-909.69
-3,650.44%
Operating Profit (PBDIT)
3,880.30
10,641.98
-6,761.68
-63.54%
Interest
0.00
1,574.99
-1,574.99
-100.00%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
11,304.60
14,787.80
-3,483.20
-23.55%
Depreciation
1,043.82
4,946.55
-3,902.73
-78.90%
Profit Before Tax
2,836.47
4,120.44
-1,283.97
-31.16%
Tax
567.31
971.86
-404.55
-41.63%
Provisions and contingencies
0
0
0.00
Profit After Tax
2,269.16
3,148.57
-879.41
-27.93%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
2,269.16
3,148.57
-879.41
-27.93%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
2,269.16
3,148.57
-879.41
-27.93%
Equity Capital
0
0
0.00
Face Value
10,000.00
10,000.00
0.00
Reserves
91,372.96
8,06,903.32
-7,15,530.36
-88.68%
Earnings per share (EPS)
453.83
228.65
225.18
98.48%
Diluted Earnings per share
453.83
228.65
225.18
98.48%
Operating Profit Margin (Excl OI)
11.15%
6.93%
0.00
4.22%
Gross Profit Margin
11.47%
10.99%
0.00
0.48%
PAT Margin
6.71%
3.82%
0.00
2.89%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 3,382.64 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 1.24% vs 20.68% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 23.53% vs 10.60% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 226.92 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 15.90% vs 671.74% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -35.24% vs 172.18% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 481.49 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 18.19% vs 71.87% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -20.38% vs 48.31% in Jun 2024

Quarterly - Interest
Markets Mojo
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.15%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024